Payers Seek Missing Link Between Diagnostic Tests And Clinical Outcomes
Personalized medicine remains a worthy goal, but for payers the evidence just isn't there yet to support reimbursement of much diagnostic testing, the Tufts Center for the Study of Drug Development concludes in its July/August Impact Report.